128 related articles for article (PubMed ID: 8668827)
1. [Human biodiversity and its effects on the pharmacological variability: CYP2D6 and NAT2 enzymes in Amerind populations of Panama, Colombia and Costa Rica].
Jorge LF; Arias TD
Rev Med Panama; 1995 Sep; 20(3):98-107. PubMed ID: 8668827
[TBL] [Abstract][Full Text] [Related]
2. Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: role of selection versus drift in world populations.
Jorge LF; Eichelbaum M; Griese EU; Inaba T; Arias TD
Pharmacogenetics; 1999 Apr; 9(2):217-28. PubMed ID: 10376769
[TBL] [Abstract][Full Text] [Related]
3. Analysis of six SNPs of NAT2 in Ngawbe and Embera Amerindians of Panama and determination of the Embera acetylation phenotype using caffeine.
Jorge-Nebert LF; Eichelbaum M; Griese EU; Inaba T; Arias TD
Pharmacogenetics; 2002 Jan; 12(1):39-48. PubMed ID: 11773863
[TBL] [Abstract][Full Text] [Related]
4. Debrisoquine polymorphism: novel CYP2D6 gene Bam HI restriction fragment length polymorphism in the Ngawbé Guaymí Indian of Panama.
Petersen DD; Kong AN; Jorge LF; Nebert DW; Arias TD
Pharmacogenetics; 1991 Dec; 1(3):136-42. PubMed ID: 1688244
[TBL] [Abstract][Full Text] [Related]
5. [Genetic diversity and racial mixture in Amerindians from Costa Rica and Panama].
Barrantes R
Rev Biol Trop; 1993 Dec; 41(3A):379-84. PubMed ID: 7701078
[TBL] [Abstract][Full Text] [Related]
6. Evolutionary pharmacogenetics of CYP2D6 in Ngawbe Guaymi of Panama: allele-specific PCR detection of the CYP2D6B allele and RFLP analysis.
Jorge LF; Arias TD; Griese U; Nebert DW; Eichelbaum M
Pharmacogenetics; 1993 Oct; 3(5):231-8. PubMed ID: 7904509
[TBL] [Abstract][Full Text] [Related]
7. [Biotransformation of sparteine in the Cuna American Indians of Panama].
Arias TD; Jorge L; Lee D; Guerrero de Solís N; Escobar J; Barrantes R; Inaba T
Rev Med Panama; 1986 Sep; 11(3):199-209. PubMed ID: 3468564
[No Abstract] [Full Text] [Related]
8. Polymorphic N-acetyltransferase (NAT2) in Amerindian populations of Panama and Colombia: high frequencies of point mutation 857A, as found in allele S3/M3.
Arias TD; Jorge LF; Griese EU; Inaba T; Eichelbaum M
Pharmacogenetics; 1993 Dec; 3(6):328-31. PubMed ID: 8148874
[No Abstract] [Full Text] [Related]
9. Cytochrome P450 genetic polymorphisms of Mexican indigenous populations.
Sosa-Macías M; Llerena A
Drug Metabol Drug Interact; 2013; 28(4):193-208. PubMed ID: 24145057
[TBL] [Abstract][Full Text] [Related]
10. [Ecologic and genetic patterns of adaptation in the Guaymi Amerindians of Costa Rica and Panama].
Barrantes R
Rev Biol Trop; 1988 Nov; 36(2A):227-33. PubMed ID: 3238075
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics in Central American healthy volunteers: interethnic variability.
Céspedes-Garro C; Naranjo ME; Ramírez R; Serrano V; Fariñas H; Barrantes R; LLerena A;
Drug Metab Pers Ther; 2015 Mar; 30(1):19-31. PubMed ID: 25490028
[TBL] [Abstract][Full Text] [Related]
12. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.
Aklillu E; Persson I; Bertilsson L; Johansson I; Rodrigues F; Ingelman-Sundberg M
J Pharmacol Exp Ther; 1996 Jul; 278(1):441-6. PubMed ID: 8764380
[TBL] [Abstract][Full Text] [Related]
13. CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, Mexico.
Sosa-Macías M; Elizondo G; Flores-Pérez C; Flores-Pérez J; Bradley-Alvarez F; Alanis-Bañuelos RE; Lares-Asseff I
J Clin Pharmacol; 2006 May; 46(5):527-36. PubMed ID: 16638736
[TBL] [Abstract][Full Text] [Related]
14. CYP2D6 gene variants in urban/admixed and Amerindian populations of Venezuela: pharmacogenetics and anthropological implications.
Griman P; Moran Y; Valero G; Loreto M; Borjas L; Chiurillo MA
Ann Hum Biol; 2012 Mar; 39(2):137-42. PubMed ID: 22324840
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in the Bribri and Cabecar Amerindians from Talamanca, Costa Rica.
Azofeifa J; Barrantes R
Rev Biol Trop; 1991 Nov; 39(2):249-53. PubMed ID: 1844158
[TBL] [Abstract][Full Text] [Related]
16. CYP2D6.10 present in human liver microsomes shows low catalytic activity and thermal stability.
Nakamura K; Ariyoshi N; Yokoi T; Ohgiya S; Chida M; Nagashima K; Inoue K; Kodama T; Shimada N; Kamataki T
Biochem Biophys Res Commun; 2002 May; 293(3):969-73. PubMed ID: 12051754
[TBL] [Abstract][Full Text] [Related]
17. Lack association between schizophrenia and the CYP2D6 gene polymorphisms.
Pirmohamed M; Wild MJ; Kitteringham NR; O'Brien K; Buchan IE; Back DJ; Park BK
Am J Med Genet; 1996 Apr; 67(2):236-7. PubMed ID: 8723057
[No Abstract] [Full Text] [Related]
18. Migration and genetic infrastructure of the Central American Guaymi and their affinities with other tribal groups.
Barrantes R; Smouse PE; Neel JV; Mohrenweiser HW; Gershowitz H
Am J Phys Anthropol; 1982 Jun; 58(2):201-14. PubMed ID: 6180642
[TBL] [Abstract][Full Text] [Related]
19. Ethnic background and CYP2D6 genetic polymorphisms in Costa Ricans.
Céspedes-Garro C; Jiménez-Arce G; Naranjo ME; Barrantes R; Llerena A;
Rev Biol Trop; 2014 Dec; 62(4):1659-71. PubMed ID: 25720195
[TBL] [Abstract][Full Text] [Related]
20. Gene-environment interaction in parkinson's disease. The case of CYP2D6 gene polymorphism.
Landi MT; Ceroni M; Martignoni E; Bertazzi PA; Caporaso NE; Nappi G
Adv Neurol; 1996; 69():61-72. PubMed ID: 8615186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
